Inne, a Berlin, Germany-based female health startup enabling women to decode their bodies, raised €8m in Series A funding.
The round was led by Blossom Capital, with participation from Monkfish Equity and notable angel investors such as Taavet Hinrikus, co-founder of TransferWise, Tom Stafford, managing partner at DST, as well as Rolf Schromgens, Trivago co-founder.
The company will use the funds to expand its team. New hires will include software engineers, design and operations members.
Founded in 2017 by Eirini Rapti, Inne is advancing a hormone tracker which empowers women to decode their bodies by leveraging technology.
The first product is a natural contraceptive without side effects, featuring a biosensor and reader as well as the connected app.
The device will be available later this year, having achieved medical certification in Europe.